CIS injection lipolysis topical products market is projected to register a substantial CAGR of 9.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.
Market Segmentation:
CIS Injection Lipolysis Topical Products Market, By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat Deposits, Buttock Fat, Knee Fat, Others), Gender (Female, Male), End-User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Countries (Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia, Rest of CIS Countries) - Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the CIS injection lipolysis topical products market are:
Technological advancements in cosmetic procedures
The rise in focus on aesthetics for beautification in males and specifically females for improving appearances
Market Segmentation:
CIS Injection Lipolysis Topical Products Market is categorized into four notable segments, which are the area of application, gender, distribution channel, and end-user.
On the basis of area of application, the market is segmented into abdominal fat, thighs fat, upper arm fat, facial fat deposits, buttock fat, knee fat, others
On the basis of gender, the market is segmented into female and male
On the basis of end-user, the market is segmented into ambulatory surgical centers (ASCS), clinics, hospitals, others
On the basis of distribution channel, the market is segmented into direct tender, retail sales, others
Market Players:
The key market players operating in the CIS injection lipolysis topical products market are listed below:
Abbvie
Leaderma Inc.
Marllor Biomedical Srl
Mesosystem
Laboratorio Innoaesthetics, S.L.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 OVERVIEW OF CIS INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET 49
1.4 LIMITATIONS 50
1.5 MARKETS COVERED 51
2 MARKET SEGMENTATION 53
2.1 MARKETS COVERED 53
2.2 GEOGRAPHICAL SCOPE 54
2.3 YEARS CONSIDERED FOR THE STUDY 55
2.4 CURRENCY AND PRICING 55
2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
2.6 AREA OF APPLICATION LIFELINE CURVE 59
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.8 DBMR MARKET POSITION GRID 61
2.9 MARKET APPLICATION COVERAGE GRID 62
2.10 VENDOR SHARE ANALYSIS 63
2.11 SECONDARY SOURCES 64
2.12 ASSUMPTIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHTS 68
4.1 PESTEL ANALYSIS 69
4.2 PORTERS FIVE FORCES 70
5 EPIDEMIOLOGY 71
5.1 INCIDENCE RATE OF ALL 71
5.2 TREATMENT RATE 71
5.3 MORTALITY RATE 72
5.4 PATIENT TREATMENT SUCCESS RATES 72
6 INDUSTRY INSIGHT 73
6.1 PATENT ANALYSIS 73
6.2 KEY PRICING STRATEGY 73
6.3 KEY PATIENT ENROLLMENT STRATEGY 73
6.4 POST SURGERY COMPLICATION 74
7 PIPELINE ANALYSIS 76
7.1 PATIENT TREATMENT SUCCESS RATES 76
8 REGIONAL ANALYSIS 77
9 CIS INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET: REGULATIONS 79
9.1 REGULATION IN EUROPE 80
10 CIS INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET, COUNTRY 81
10.1 RUSSIA 82
10.2 KAZAKHSTAN 92
10.3 BELARUS 102
10.4 CROATIA 112
10.5 AZERBAIJAN 122
10.6 MOLDOVA 132
10.7 ARMENIA 142
10.8 KYRGYZSTAN 152
10.9 UKRAINE 162
10.10 SERBIA 172
10.11 REST OF CIS COUNTRIES 182
11 CIS INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET: COMPANY LANDSCAPE 183
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 183
12 COMPANY PROFILE 184
12.1 ABBVIE INC 184
12.1.1 COMPANY SNAPSHOT 184
12.1.2 REVENUE ANALYSIS 184
12.1.3 PRODUCT PORTFOLIO 185
12.1.4 RECENT DEVELOPMENTS 185
12.2 LEADERMA, INC 186
12.2.1 COMPANY SNAPSHOT 186
12.2.2 PRODUCT PORTFOLIO 186
12.2.3 RECENT DEVELOPMENT 186
12.3 MARLLOR BIOMEDICAL SRL 187
12.3.1 COMPANY SNAPSHOT 187
12.3.2 PRODUCT PORTFOLIO 187
12.3.3 RECENT DEVELOPMENT 187
12.4 MESOSYSTEMS 188
12.4.1 COMPANY SNAPSHOT 188
12.4.2 PRODUCT PORTFOLIO 188
12.4.3 RECENT DEVELOPMENT 188
12.5 SIMILDIET S.L 189
12.5.1 COMPANY SNAPSHOT 189
12.5.2 PRODUCT PORTFOLIO 189
12.5.3 RECENT DEVELOPMENT 189
12.6 MESOMEDICA 190
12.6.1 COMPANY SNAPSHOT 190
12.6.2 PRODUCT PORTFOLIO 190
12.6.3 RECENT DEVELOPMENT 190
12.7 REXPHARMA 191
12.7.1 COMPANY SNAPSHOT 191
12.7.2 PRODUCT PORTFOLIO 191
12.7.3 RECENT DEVELOPMENT 191
12.8 SANOFI 192
12.8.1 COMPANY SNAPSHOT 192
12.8.2 REVENUE ANALYSIS 192
12.8.3 PRODUCT PORTFOLIO 193
12.8.4 RECENT DEVELOPMENTS 193
13 QUESTIONNAIRE 194
14 RELATED REPORTS 196
Segmentation
Short Description
CIS Injection Lipolysis Topical Products Market, By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat, Buttock Fat, Knee Fat), Gender (Male and Female), End User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, and others) Distribution Channel (Direct Tender, Retail Sales and Others), Countries ( Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia and Rest of CIS Countries) Industry Trends & Forecast to 2029.
Market Definition:
Injection lipolysis chemically reduces the number of fat cells around the injection site. The chemical, called deoxycholic acid, results in fat cell disruption and death. Injection lipolysis is a commonly encountered entity in dermatology practice and is a non-surgical procedure.
The demand for injection lipolysis topical products has increased in developed and developing countries. This is the increasing prevalence of eye disorders and product launches. The injection lipolysis topical products market is growing due to introduction of innovative products, increasing technological products, and rising disposable income. The market will grow in the forecasted period due to exploring emerging markets, strategic initiatives by market players, and increasing healthcare expenditure.
Market Segmentation:
CIS injection lipolysis topical products market is categorized into four notable segments: application, gender, end-user, and distribution channel.
On the basis of devices, the CIS injection lipolysis topical products market is segmented into abdominal fat, thighs fat, upper arm fat, facial fat, buttock fat, and knee fat. In 2022, the abdominal fat segment is expected to dominate the CIS injection lipolysis topical products market due to the increased prevalence of obesity recently all over the developed country
On the basis of gender, the CIS injection lipolysis topical products market is segmented into females and males. In 2022, female is expected to dominate the CIS injection lipolysis topical products market with the increasingly advanced technology and rising awareness program
On the basis of end-user, the CIS injection lipolysis topical products market is segmented into hospitals, clinics, ambulatory surgical centers (ASCS), and others. In 2022, the hospital segment is expected to dominate the CIS injection lipolysis topical products market with the increasing number of patients and surgeries
On the basis of distribution channel, the CIS injection lipolysis topical products market is segmented into direct tender, retail sales, and others. In 2022, direct tender is expected to dominate the CIS injection lipolysis topical products market, with a wide range of products available through this distribution channel
Market Players
The key market players for CIS injection lipolysis topical products market are listed below:
Abbvie Inc.,
Leaderma Inc.
Marllor Biomedical Srl
Mesosystem
SIMILDIET S.L,
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
